Opendata, web and dolomites

AllergyExplorer SIGNED

Automation of novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AllergyExplorer project word cloud

Explore the words cloud of the AllergyExplorer project. It provides you a very rough idea of what is the project "AllergyExplorer" about.

instead    enhanced    immunotherapy    asthma    optimal    solution    selling    molecular    almost    profile    bn    device    140    population    declared    half    revenues    expand    forcing    clinical    registered    risk    therapeutic    estimate    insufficiently    customers    public    technically    delivering    rate    select    substantiates    medical    labs    market    vitro    segments    double    saved    21st    valuable    amounted    single    eliminate    century    fast    recommendations    diagnosed    annual    lab    few    instrumentation    globally    de    individual    allergy    prior    complete    time    multiply    return    spent    validated    off    avoidance    customer    2016    health    allergen    allergies    union    patients    approx    supplier    experts    100    million    usd    clearer    practitioners    automated    allergic    trade    points    adequately    tested    quality    700    life    independent    immunological    close    least    facto    provides    manual    anamnesis    diagnosis    quarter    monopoly    digit    decision    pressure    treatment    automate    diagnostics    jobs    global    allergens    routine   

Project "AllergyExplorer" data sheet

The following table provides information about the project.

Coordinator
MACROARRAY DIAGNOSTICS GMBH 

Organization address
address: GUTHEIL SCHODER GASSE 17 TECHPARK VIENNA STIEGE 3
city: WIEN
postcode: 1230
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 3˙536˙250 €
 EC max contribution 2˙475˙375 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MACROARRAY DIAGNOSTICS GMBH AT (WIEN) coordinator 2˙475˙375.00

Map

 Project objective

Allergies and asthma affect at least a quarter of the population and the WHO has declared allergy a major health problem of the 21st century. Currently, medical practitioners must pre-select very few allergens for in-vitro testing, based on prior anamnesis, under time and cost pressure. Independent experts estimate that almost half of the patients are diagnosed insufficiently. The consequences for the patients are not optimal treatment and reduced quality of life. For the public health systems more than 140 Bn Euro are spent each year which could be saved if all allergic patients were treated adequately. We have developed a multi-parameter allergy test covering close to 100% of the globally relevant allergens in a single lab test. Instead of forcing medical practitioners to pre-select very few allergens for in-vitro, our solution substantiates any therapeutic decision by offering a complete immunological profile for every tested individual. We expand testing to the molecular level which provides valuable decision points such as enhanced risk assessment, improving the success of allergen immunotherapy or clearer recommendations for avoidance. We eliminate the trade-off between cost and quality of allergy diagnosis. Our allergy test is technically validated and registered as an in-vitro diagnostics device in Europe. We are already selling and delivering the non-automated manual test systems to customers all over Europe. In this project, we will fully automate the test instrumentation so we can target the customer segments of highly automated clinical routine labs. This will multiply our selling potential and expand our customer reach. The global market of in-vitro diagnosis of allergy is growing fast at almost double-digit rate globally, and amounted to approx. 700 million USD annual revenues in 2016. There is a de-facto monopoly of a single US supplier and this project will return jobs and revenues to the European Union.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALLERGYEXPLORER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ALLERGYEXPLORER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More  

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More